<table id="id_6892ef10-b937-489a-ac1b-582454acc103" width="445.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_15fcf147-182a-4f5d-9875-efebb5eb106e">Table 3: Results of Drug Interaction Studies with Didanosine Delayed-Release Capsules: Effects of Coadministered Drug on Didanosine Plasma AUC and Cmax Values<sup>a</sup>
</caption>
<col width="19.3%"></col>
<col width="22.7%"></col>
<col width="7.4%"></col>
<col width="23.4%"></col>
<col width="27.2%"></col>
<tbody>
<tr id="id_aacecdfb-31ba-45e8-940c-5b504f31475e">
<td align="left" stylecode="Botrule Toprule Rrule" valign="top">Drug</td>
<td align="center" stylecode="Botrule Rrule" valign="top">Didanosine Dosage</td>
<td align="center" stylecode="Botrule Rrule" valign="top">n</td>
<td align="center" stylecode="Botrule Rrule" valign="top">AUC of Didanosine (90% CI)</td>
<td align="center" stylecode="Botrule" valign="top">Cmax of Didanosine (90% CI)</td>
</tr>
<tr id="id_5ac161a3-a223-4950-bbb4-83cee26ed1db">
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">tenofovir</content>,<sup>b</sup>
</paragraph>
<paragraph>300 mg once daily with a light meal<sup>c</sup>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">400 mg single dose fasting 2 h before tenofovir</td>
<td align="center" stylecode="Botrule Rrule" valign="top">26</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>↑ 48%<br/>(31, 67%)</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 48%<br/>(25, 76%)</paragraph>
</td>
</tr>
<tr id="id_fbf39d70-8fad-4e71-903a-83606ba53a8f">
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">tenofovir</content>,<sup>b</sup>
</paragraph>
<paragraph> 300 mg once daily with a light meal<sup>c</sup>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">400 mg single dose with tenofovir and a light meal</td>
<td align="center" stylecode="Botrule Rrule" valign="top">25</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>↑ 60% <br/>(44, 79%)</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 64% <br/>(41, 89%)</paragraph>
</td>
</tr>
<tr id="id_32ed40c7-ef72-40a7-a6e8-345912f1f756">
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">tenofovir</content>,<sup>b</sup>
</paragraph>
<paragraph> 300 mg once daily with a light meal<sup>c</sup>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>200 mg single dose with tenofovir and a light meal</paragraph>
<paragraph>250 mg single dose with tenogovir and a light meal</paragraph>
<paragraph>325 mg single dose with tenofovir and a light meal</paragraph>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>33</paragraph>
<paragraph>33</paragraph>
<paragraph>33</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↑ 16%<br/>(6, 27%)<sup>d</sup>
</paragraph>
<paragraph>↔(-13, 5%)<sup>e</sup>
</paragraph>
<paragraph> </paragraph>
<paragraph> ↑ 13%</paragraph>
<paragraph>(3, 24%)</paragraph>
</td>
<td align="left" stylecode="Botrule" valign="top">
<paragraph>↓ 12%<br/>(-25, 3%)<sup>d</sup>
</paragraph>
<paragraph>↓ 20%<br/>(-32, -7%)<sup>e</sup>
</paragraph>
<paragraph>↓ 11%<br/>(-24, 4%)<sup>e</sup>
</paragraph>
</td>
</tr>
<tr id="id_93c250ad-79c6-4934-9ec4-ce2268dd8e7c">
<td align="left" colspan="5" stylecode="Lrule Botrule" valign="top">
<paragraph>↑ indicates increase.</paragraph>
<paragraph>↓ indicates decrease.</paragraph>
<paragraph>↔ indicates no change, or mean increase or decrease of &lt;10%.</paragraph>
<paragraph>
<sup>a</sup> All studies conducted in healthy volunteers ≥60kg with creatinine clearance ≥60 <br/> mL/min.<br/>
<sup>b</sup> tenofovir disporoxil fumarate.<br/>
<sup>c</sup> 373 kcalories, 8.2 grams fat.<br/>
<sup>d</sup> Compared with didanosine delayed-release capsules 250 mg administered alone under <br/> fasting coniditions.<br/>
<sup>e</sup> Compared with didanosine delayed-release capsules 400 mg administered alone under </paragraph>
<paragraph> fasting conditions.</paragraph>
</td>
</tr>
</tbody>
</table>